Eng

China enlists Huawei, Tencent, Ant Financial in national blockchain committee to set standards

South China Morning Post
發布於 2020年04月16日13:04 • Sarah Dai and Yujie Xue sarah.dai@scmp.com; yujie.xue@scmp.com
  • The initiative marks a major step forward to achieve mainstream adoption of blockchain technology across China’s industries
  • The committee also includes Baidu, and JD.com
China’s National Blockchain and Distributed Accounting Technology Standardisation Technical Committee will gather researchers and experts from the government, think tanks, universities, supercomputing centres and major hi-tech companies. Photo: Shutterstock

China has formed a national blockchain committee, which enlists the support of some of the country's largest hi-tech companies to draw up standards for use of the technology across industries.

This group includes telecommunications equipment maker Huawei Technologies, video games and social media powerhouse Tencent Holdings, Chinese online search market leader Baidu, fintech company Ant Financial Services and e-commerce giant JD.com, according to a statement released earlier this week by the Ministry of Industry and Information Technology (MIIT).

廣告(請繼續閱讀本文)

The so-called National Blockchain and Distributed Accounting Technology Standardisation Technical Committee will gather more than 70 researchers and experts from the MIIT, local governments, state think tanks, universities, supercomputing centres and the hi-tech companies, the statement said.

It also said MIIT vice-minister Chen Zhaoxiong will serve as chairman of the committee, but gave no details on how the group is expected to function.

Baidu had no comment on the blockchain committee's formation. Huawei, Tencent, JD.com, Ant Financial and the MIIT did not immediately respond to separate inquiries for comment. Ant Financial is an affiliate of Alibaba Group Holding, which is the parent company of the South China Morning Post.

廣告(請繼續閱讀本文)

The MIIT-led initiative marks a major step forward to help achieve mainstream adoption of blockchain technology, which President Xi Jinping endorsed on October 24 last year as vital for China to strengthen its digital economy.

In his speech last October, Xi called for more blockchain-related research and development. He also highlighted the technology's use in a range of applications, from credit checks, health care and anti-counterfeiting to food security and charities.

Blockchain, the digital ledger technology behind cryptocurrencies like bitcoin, allows participants to create, disseminate and store information in a shared database in an efficient and secure manner. It records and stores every transaction or exchange of data that occurs in the network, essentially eliminating the need for a central authority and providing greater transparency for regulatory reporting.

廣告(請繼續閱讀本文)

The initial interest in blockchain had largely been in financial services, especially in digital currency, payment processing, and market trading and settlement.

What Xi Jinping's blockchain advocacy means for China " and the world

The MIIT's announcement is likely to bolster recent blockchain-related programmes in the world's second largest economy.

China's Blockchain-based Service Network, a platform under the State Information Centre, is set to launch on April 25, with the goal of helping more companies deploy applications based on the technology faster and cheaper, according to state media.

On Thursday, Ant Financial launched its own blockchain platform called OpenChain. It is designed to help small enterprises use the company's blockchain-powered smart contracts and apps.

"Applications of blockchain technology have ballooned over the past years," said Jin Ge, general manager of Ant Financial's blockchain platform. He indicated that the company aims to help one million small- and medium-sized enterprises as well as developers create more use cases for blockchain in the next three years through its platform.

Blockchain had become more widely adopted by China's major tech firms as early as 2016. Tencent, for example used blockchain for gaming and charitable projects, while Alibaba used the technology to help keep track of medical prescriptions, charitable donations and cross-border remittances. With Xi throwing his weight behind the technology last year, blockchain received an extra push across businesses and the government.

Additional reporting by Jane Zhang

Sign up now and get a 10% discount (original price US$400) off the China AI Report 2020 by SCMP Research. Learn about the AI ambitions of Alibaba, Baidu & JD.com through our in-depth case studies, and explore new applications of AI across industries. The report also includes exclusive access to webinars to interact with C-level executives from leading China AI companies (via live Q&A sessions). Offer valid until 31 May 2020.

Copyright (c) 2020. South China Morning Post Publishers Ltd. All rights reserved.

查看原始文章

更多 Eng 相關文章

New Doraemon movie stays atop China's box office chart
XINHUA
Red deer calf rescued in NW China's Xinjiang
XINHUA
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
PR Newswire (美通社)
Update: China's Chang'e-6 lands on moon's far side to collect samples
XINHUA
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
PR Newswire (美通社)
Cambodia's famed Angkor sees 37-pct rise in int'l tourists in first 5 months
XINHUA
Scenic highway in Xinjiang opens to traffic following seasonal closure
XINHUA
Asia Album: Travel with China's train at Asia Pacific Rail 2024
XINHUA
GLOBALink | Vlog: "Ancient yet modern, truly impressive" - A dialogue with foreign tourists in Xi'an
XINHUA
Russia's Progress MS-27 cargo spacecraft docks at ISS
XINHUA
Turkish economy grows by 5.7 pct in Q1
XINHUA
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
PR Newswire (美通社)
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
PR Newswire (美通社)
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
PR Newswire (美通社)
COFCO's sustainable soybean shipment arrives at Tianjin Port in N China
XINHUA
Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
PR Newswire (美通社)
(Poster) What Manila wants you to believe versus what facts tell about South China Sea issue (9)
XINHUA
EyesOnSci | China's Chang'e-6 lands on moon's far side to collect samples
XINHUA
Xinhua News | Scenic highway in China's Xinjiang opens to traffic following seasonal closure
XINHUA